Design and Synthesis of Highly Potent HIV-1 Protease Inhibitors Containing Tricyclic Fused Ring Systems as Novel P2 Ligands: Structure-Activity Studies, Biological and X-ray Structural Analysis / Ghosh, A.K., Nyalapatla, R.P., Kovela, S., Rao, K.V., Brindisi, M., Osswald, H.L., Amano, M., Aoki, M., Agniswamy, J., Wang, Y.-F., Weber, I.T., Mitsuya, H.. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 61:10(2018), pp. 4561-4577. [10.1021/acs.jmedchem.8b00298]

Design and Synthesis of Highly Potent HIV-1 Protease Inhibitors Containing Tricyclic Fused Ring Systems as Novel P2 Ligands: Structure-Activity Studies, Biological and X-ray Structural Analysis

Brindisi M.;
2018

2018
Design and Synthesis of Highly Potent HIV-1 Protease Inhibitors Containing Tricyclic Fused Ring Systems as Novel P2 Ligands: Structure-Activity Studies, Biological and X-ray Structural Analysis / Ghosh, A.K., Nyalapatla, R.P., Kovela, S., Rao, K.V., Brindisi, M., Osswald, H.L., Amano, M., Aoki, M., Agniswamy, J., Wang, Y.-F., Weber, I.T., Mitsuya, H.. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 61:10(2018), pp. 4561-4577. [10.1021/acs.jmedchem.8b00298]
File in questo prodotto:
File Dimensione Formato  
acs.jmedchem.8b00298.pdf

non disponibili

Dimensione 3.14 MB
Formato Adobe PDF
3.14 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/771083
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 35
  • ???jsp.display-item.citation.isi??? 32
social impact